Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01992003 · ClinicalTrials.gov registry record
Butterfly Sensor With Rev K Version
A clinical trial, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- 9
- Enrollment target
NCT01992003: Clinical Trial study, sponsored by University of California, San Francisco.
NCT01992003 is a clinical trial that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01992003 was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- 9 participants
- Enrollment target
Study Summary
The primary purpose of this study is to assess the accuracy of the newly released Masimo SpHb Butterfly Sensor with RevK version and compare the results to a blood hemoglobin level analyzed in the UCSF Clinical Laboratories. A secondary purpose is to assess the blood hemoglobin using the Masimo Pronto-7 hand-held device immediately prior to surgery.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2014-01 |
| Est. Completion | 2014-12 |
Why NCT01992003 stopped before completion
NCT01992003 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 9 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01992003 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01992003 about?
NCT01992003 is a clinical study titled "Butterfly Sensor With Rev K Version". The primary purpose of this study is to assess the accuracy of the newly released Masimo SpHb Butterfly Sensor with RevK version and compare the results to a blood hemoglobin level analyzed in the UCSF Clinical Laboratories. A secondary purpose is to assess the blood hemoglobin using the Masimo Pron...
What is the current status of trial NCT01992003?
This trial is currently terminated. The enrollment target is 9 participants. The study started on 2014-01. Estimated completion is 2014-12.
Who is sponsoring clinical trial NCT01992003?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia